Kallikrein Gene-Modified EPCs Induce Angiogenesis in Rats with Ischemic Hindlimb and Correlate with Integrin αvβ3 Expression

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Fu, Shen Shen ^a   Li, Fu Ji ^a   Wang, Yuan Yuan ^a   You, An Bei ^a   Qie, Yi Liang ^a   Meng, Xiao ^a   Li, Jian Rui ^a   Li, Bao Chuan ^a   Zhang, Yun ^a   Da Li, Qing ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GREEN FLUORESCENT PROTEIN; KALLIKREIN; PHOSPHATIDYLINOSITOL 3 KINASE; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CELL ADHESION; CELL COUNT; CELL MIGRATION; CELL SURFACE; CELL TRANSFORMATION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; ENZYME INHIBITION; FEMALE; GENE FUNCTION; HINDLIMB; HUMAN TISSUE KALLIKREIN GENE; IN VITRO STUDY; LIMB ISCHEMIA; MUSCLE BLOOD FLOW; MUSCLE CAPILLARY; MUSCLE CELL; MUSCULAR CAPILLARY DENSITY; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM; WISTAR RAT;

ANIMALS; ENDOTHELIUM; FEMALE; HINDLIMB; INTEGRIN ALPHAVBETA3; ISCHEMIA; KALLIKREINS; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, WISTAR; STEM CELLS; TRANSFECTION;

EID: 84883332041     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073035     Document Type: Article

References (44)

1. Marković A, (2012) Vasculitis and vasculopathy. Acta Med Croatica 66Suppl 1: 19-24.
2. Losordo DW, Dimmeler S, (2004) Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part II: Cell-based therapies. Circulation 109: 2692-2697.
3. Tongers J, Roncalli JG, Losordo DW, (2010) Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation. Microvasc Res 79: 200-206.
4. Caiado F, Dias S (2012) Endothelial progenitor cells and integrins: adhesive needs. Caiado and Dias Fibrogenesis & Tissue Repair. Available: http://www.fibrogenesis.com/content/5/1/4.
5. Ceradini DJ, Gurtner GC, (2005) Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends in Cardiovascular Medicine 15: 57-63.
6. Coultas L, Chawengsaksophak K, Rossant J, (2005) Endothelial cells and VEGF in vascular development. Nature 438: 937-945.
7. Young PP, Hofling AA, Sands MS, (2002) VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients. PNAS 99: 11951-11956.
8. Thisse B, Thisse C, (2005) Functions and regulations of fibroblast growth factor signaling during embryonic development. Developmental Biology 287: 390-402.
9. Asai J, Takenaka H, Ii M, Asahi M, Kishimoto S, et al. (2012) Topical application of ex vivo expanded endothelial progenitor cells promotes vascularisation and wound healing in diabetic mice. Int Wound J doi: 10.1111/j.1742-481X.2012.01010.x.
10. ten Dijke P, Arthur HM, (2007) Extracellular control of TGFbeta signalling in vascular development and disease. Nature Reviews Molecular Cell Biology 8: 857-869.
11. Lange S, Heger J, Euler G, Wartenberg M, Piper HM, et al. (2009) Platelet-derived growth factor BB stimulates vasculogenesis of embryonic stem cell-derived endothelial cells by calcium-mediated generation of reactive oxygen species. Cardiovascular Research 81: 159-168.
12. Estrada R, Zeng Q, Lu H, Sarojini H, Lee JF, et al. (2008) Up-regulating sphingosine 1-phosphate receptor-2 signaling impairs chemotactic, wound healing, and morphogenetic responses in senescent endothelial cells. The Journal of Biological Chemistry 283: 30363-30375.
13. Liu Y, Min D, Bolton T, Nubé V, Twigg SM, et al. (2009) Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers. Diabetes Care 32: 117-119.
14. Fang S, Pentinmikko N, Ilmonen M, Salven P, (2012) Dual action of TGF-beta induces vascular growth in vivo through recruitment of angiogenic VEGF-producing hematopoietic effector cells. Angiogenesis 15: 511-519.
15. Schroeter MR, Leifheit M, Sudholt P, Heida NM, Dellas C, et al. (2008) Leptin enhances the recruitment of endothelial progenitor cells into neointimal lesions after vascular injury by promoting integrin-mediated adhesion. Circ Res 103: 536-544.
16. Hiasa K, Ishibashi M, Ohtani K, Inoue S, Zhao Q, et al. (2004) Gene transfer of stromal cell-derived factor-1 enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: nextgeneration chemokine therapy for therapeutic neovascularization. Circulation 109: 2454-2461.
17. Iwaguro H, Yamaguchi J, Kalka C, Murasawa S, Masuda H, et al. (2002) Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 105: 732-738.
18. Morishita R, Aoki M, Hashiya N, Makino H, Yamasaki K, et al. (2004) Safety Evaluation of Clinical Gene Therapy Using Hepatocyte Growth Factor to Treat Peripheral Arterial Disease. Hypertension 44: 203-209.
19. Lara-Hernández R, Lozano-Vilardell P, Cordobés-Gual J, (2008) Novel therapies of non-revascularizing peripheral arterial occlusive disease: therapeutic angiogenesis. Med Clin (Barc) 131(17): 665-669.
20. Belkin AM, Stepp MA, (2000) Integrins as receptors for laminins. Microsc Res Tech 51: 280-301.
21. Morbidelli L, Parenti A, Giovannelli L, Granger HJ, Ledda F, et al. (1998) B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects. Br J Pharmacol 124: 1286-1292.
22. Emanueli C, Zacheo A, Minasi A, Chao J, Chao L, et al. (2000) Adenovirus-mediated human tissue kallikrein gene delivery induces angiogenesis in normoperfused skeletal muscle. Arterioscler Thromb Vasc Biol 20: 2379-2385.
23. Stone OA, Richer C, Emanueli C, van Weel V, Quax PH, et al. (2009) Critical role of tissue kallikrein in vessel formation and maturation: implications for therapeutic revascularization. Arterioscler Thromb Vasc Biol 29(5): 657-664.
24. Zhang JJ, Chao L, Chao J, (1999) Adenovirus-mediated kallikrein gene delivery reduces aortic thickening and stroke-induced death rate in Dahl salt-sensitive rats.Stroke. 30(9): 1925-1931.
25. Yoshida H, Zhang JJ, Chao L, Chao J, (2000) Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion. Hypertension 35(1 Pt 1): 25-31.
26. Spinetti G, Fortunato O, Cordella D, Portararo P, Kränkel N, et al. (2011) Tissue kallikrein is essential for invasive capacity of circulating proangiogenic cells. Circ Res 108(3): 284-293.
27. Young PP, Hofling AA, Sands MS, (2002) VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients. PNAS 99: 11951-11956.
28. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, et al. (2000) Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. PNAS 97: 3422-3427.
29. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, et al. (2001) Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7: 430-436.
30. Fan Y, Shen F, Frenzel T, Zhu W, Ye J, et al. (2010) Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. Ann Neurol 67(4): 488-497.
31. Nakamura T, Torimura T, Sakamoto M, Hashimoto O, Taniguchi E, et al. (2007) Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model. Gastroenterology 133: 91-107.
32. Liu X, Li Y, Liu Y, Luo Y, Wang D, et al. (2010) Endothelial progenitor cells (EPCs) mobilized and activated by neurotrophic factors may contribute to pathologic neovascularization in diabetic retinopathy. Am J Pathol 176: 504-515.
33. Torsney E, Mandal K, Halliday A, Jahangiri M, Xu Q, (2007) Characterization of progenitor cells in human atherosclerotic vessels. Atherosclerosis 191: 259-264.
34. Jiao LF, Zhang JN (2008) Marking of rat EPCs and changes in circulating rat EPCs after TBI. Tianjin Medical University master's graduation thesis-abstract I II. (Chinese).
35. Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, et al. (2008) Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 319: 195-198.
36. Spinetti G, Fortunato O, Cordella D, Portararo P, Kränkel N, et al. (2011) Tissue Kallikrein Is Essential for Invasive Capacity of Circulating Proangiogenic Cells. Circ Res108: 284-293.
37. Stone OA, Richer C, Emanueli C, Vincent van Weel, Paul HA, et al. (2009) Critical Role of Tissue Kallikrein in Vessel Formation and Maturation: Implications for Therapeutic Revascularization. Arterioscler Thromb Vasc Biol 29(5): 657-664.
38. Wijelath ES, Rahman S, Murray J, Patel Y, Savidge G, et al. (2004) Fibronectin promotes VEGF-induced CD34+ cell differentiation into endothelial cells. J Vasc Surg 39: 655-660.
39. Hildbrand P, Cirulli V, Prinsen RC, Smith KA, Torbett BE, et al. (2004) The role of angiopoietins in the development of endothelial cells from cord blood CD34+ progenitors. Blood 104: 2010-2019.
40. Murohara T, Witzenbichler B, Spyridopoulos I, Asahara T, Ding B, et al. (1999) Role of endothelial nitric oxide synthase in endothelial cell migration. Arterioscler Thromb Vasc Biol 19(5): 1156-1161.
41. Rössig L, Urbich C, Brühl T, Dernbach E, Heeschen C, et al. (2005) Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells. J Exp Med 201: 1825-1835.
42. Folkman J, (2007) Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 6: 273-286.
43. Stupack DG, Cheresh DA, (2004) Integrins and angiogenesis. Curr Top Dev Biol 64: 207-238.
44. Wu Y, Dai J, Schmuckler NG, Bakdash N, Yoder MC, et al. (2010) Cleaved high molecular weight kininogen inhibits tube formation of endothelial progenitor cells via suppression of matrix metalloproteinase 2. J Thromb Haemost 8(1): 185-193.